A Ras-dependent signaling pathway regulates global RNA and protein synthesis in cardiac myocytes via phosphorylation of RNA polymerase II, providing a molecular mechanism for the development of cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Ras inhibition does not yet inform clinical hypertrophy management; leaves open pathway targeting for human validation.
Abdellatif et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: